Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
WorkCompWire: Ron Skrocki: Medication Management: A Growing Problem Requiring a Collaborative Effort
In his article, "Medication Management: A Growing Problem Requiring a Collaborative Effort," Ron Skrocki, Senior Vice President at Genex Services, addresses the persistent issue of opioid misuse in workers' compensation.
Reducing Human Error in Utilization Review Decision Making
Read this informative insight paper to find out how you can assure injured workers receive the best care protocol while eliminating the costly repercussions of human error.
Taking Heart in Workers' Comp
Genex honors three difference-making case management professionals through new Heart of Case Management AwardWAYNE, PA - April 11,
Making Better UR Decisions at the Desk Level
Genex brings together the heart and science of utilization review to extend overall medical quality
StateWatch Spring 2016
Medication Safety: How Do We Solve the Problem?
Genex’s Ron Skrocki discussed why medication safety remains a significant problem in workers’ comp. In this edition, Skrocki offers effective solutions with real results in helping injured workers return to the job without the burden of opioid dependence.